Earnings History Data for CNS Pharmaceuticals, Inc. (CNSP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals Inc. is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. The company's lead drug includes Berubicin, for the treatment of Glioblastoma Multiforme and potentially for other CNS malignancies. CNS Pharmaceuticals Inc. is based in Houston, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
13-08-2021 PM CNSP Cns Pharmaceuticals, Inc. 42.00 -0.15 -0.16 0.00 CNS Pharmaceuticals reports Q2 results
[8/13/2021 8:47 AM]
1.66 0.03 
(1.84%)
1.68 0.05 
(3.07%)
1.62 - 4.46 100,398 90,000 894